NCT03192007

Brief Summary

The goals of this study are:

  • To optimize and evaluate multiple kidney MRI methods; and
  • To investigate the potential of MRI in the assessment of transplant kidney functions; To achieve these goals, we will perform pilot MRI studies with kidney transplant patients. We will study if MRI can reflect different levels of kidney function. The investigators will also evaluate if MRI can differentiate causes for declining kidney function. Finally, the investigators will explore how MRI measures changes before and after medical treatment for worsening kidney function. You may be invited for MRI exams with different exam options. An MRI exam may use either of two types of MRI machines at the center for magnetic resonance research (CMRR): the 3 Tesla (3T) scanner and the 7 Tesla (7T) scanner. You may also be invited for a multi-session exam. A description of the MRI exam types with different exam options and the types of multi-session exams is provided later in this document.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Jul 2027

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 19, 2017

Completed
10 years until next milestone

Study Start

First participant enrolled

July 1, 2027

Expected
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

September 29, 2025

Status Verified

September 1, 2025

Enrollment Period

1.5 years

First QC Date

May 9, 2017

Last Update Submit

September 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anatomic and functional MRI characteristics in transplant kidneys with stable renal function

    Investigate the correlations between anatomic and functional characteristics by MRI and the level of transplant renal function

    Baseline

Secondary Outcomes (1)

  • Anatomic and functional MRI characteristics of transplant kidneys with transplant complications

    Baseline

Study Arms (2)

Patients with Stable Renal Function

Patients will be given MRI

Device: Magnetic Resonance Imaging

Patients with Worsening Renal Function due to complications

MRI

Device: Magnetic Resonance Imaging

Interventions

Investigate anatomic and functional characteristics of transplant kidneys using MRI

Also known as: MRI
Patients with Stable Renal FunctionPatients with Worsening Renal Function due to complications

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The proposed studies are pilot studies to obtain preliminary data for the development of hypotheses and estimate the power for future large-scale studies. To accomplish the objectives of the proposed pilot studies, we will enroll a total of 140 renal transplant patients. Based on our previous experience, there will be about 20% patients who may withdraw after informed consent. Equal number of male and female subjects will be recruited for each patient group. In addition, the age of patients will be matched or ensured insignificant across the groups of the study objectives.

You may qualify if:

  • Renal Transplant Recipients
  • Capable to consent
  • English speaking
  • For studies with patients with fast worsening renal function: An abrupt (within 48 h) reduction in kidney function currently defined as a percentage increase in serum creatinine of ≥50% (1.5-fold from baseline), or a reduction in urine output (documented oliguria of less than 0.5 mL/kg/h for more than 6 h).
  • For patients with recovered renal allograft function after therapy: renal allograft function as measured by glomerular filtration rate (eGRF) has been recovered and stabilized above a clinical acceptable level, such as 15 ml/min/1.73 mm2.

You may not qualify if:

  • On dialysis due to renal allograft failure
  • Acute and chronic pulmonary disease
  • Pregnancy as reported in CMRR Safety Screen
  • Ferromagnetic implants
  • Any foreign metal objects in the body
  • History of shrapnel or shot gun injury
  • Cardiac pacemakers
  • Defibrillator
  • Neuronal stimulator
  • Magnetic aneurysm clip
  • Large tattoos on the abdomen or the brain and neck, as determined by CMRR Safety Officer
  • Hip replacement
  • Too large to fit in the magnet (BMI \>= 40, approx.)
  • Severe claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CMMR

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Interventions

Magnetic Resonance Imaging

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2017

First Posted

June 19, 2017

Study Start (Estimated)

July 1, 2027

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

September 29, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations